NTEG- Bloodless Glucose Monitor Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTEG- Bloodless Glucose Monitor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tevyah who wrote (21)	9/14/1997 12:13:00 AM
From: Stratajema	of 176

Ken. My estimate of the design freeze is based on the the general tasks that still need to be completed. (Management was understandably vague on this matter in the last conference call.) Please be assured that my estimate is based on nothing more than a gut feel, subject to change. My read on the recent appointment of a new R&D director indicates much more work needs to be done on this revolutionary device. During the last quarterly conference call Integ said their ISF studies will be published this fall in Diabetes Care and the Journal of Laboratory and Clinical Medicine. The Frost & Sullivan report costs big bucks to obtain. There isn't any information in the report that can't be obtained by good old fashioned individual research. Time for me to go back into hybernation on SI. Good luck with your trades.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next